The Case for Reactive Mass Oral Cholera Vaccinations
2011

The Case for Reactive Mass Oral Cholera Vaccinations

Sample size: 13490000 publication 10 minutes Evidence: high

Author Information

Author(s): Rita Reyburn, Jacqueline L. Deen, Rebecca F. Grais, Sujit K. Bhattacharya, Dipika Sur, Anna L. Lopez, Mohamed S. Jiddawi, John D. Clemens, Lorenz von Seidlein

Primary Institution: International Vaccine Institute (IVI), Seoul, Korea

Hypothesis

Can reactive mass oral cholera vaccinations significantly reduce cholera cases during outbreaks?

Conclusion

Reactive vaccine use can prevent cholera cases and is a rational response to cholera outbreaks in both endemic and non-endemic settings.

Supporting Evidence

  • 34,900 cholera cases and 1,695 deaths could have been prevented in Zimbabwe with a rapid vaccination response.
  • Vaccination campaigns can significantly reduce cholera cases in both endemic and non-endemic settings.
  • Even delayed vaccination responses can save a substantial number of cases and deaths.
  • A single-dose vaccine would be advantageous in short outbreaks.

Takeaway

If we give cholera vaccines quickly during an outbreak, we can stop a lot of people from getting sick.

Methodology

Data from cholera outbreaks in Zimbabwe, Kolkata, and Zanzibar were analyzed to estimate preventable cases under different vaccination scenarios.

Potential Biases

Potential underreporting of cholera cases and reliance on clinical diagnoses may introduce bias.

Limitations

The study may not represent all cholera outbreaks and relied on existing data, which could be incomplete.

Participant Demographics

The study included populations from Zimbabwe, Kolkata (India), and Zanzibar (Tanzania), with varying cholera endemicity.

Digital Object Identifier (DOI)

10.1371/journal.pntd.0000952

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication